Management of Obstetrics and Gynecological Patients with COVID-19

Abstract

Since December 2019, the Coronavirus illness, commonly known as COVID19, has quickly spread from Wuhan, China. The first COVID-19 patient was identified in Italy on February 20, 2020, and developed respiratory failure, prompting hospitalization to the critical care unit (ICU). For more than a year, the highly contagious and lethal coronavirus illness has been causing havoc on the earth. It has progressed to a pandemic level affecting the lives of millions around the globe. The condition can afflict anybody, and there is currently no definitive treatment. Pregnant women do not appear to be more susceptible to infection than the general population. On the other hand, pregnant women have a different immune system and a stronger overall response to viral infections, which could lead to more severe symptoms in some cases, such as COVID-19. COVID-19 presents a minimal overall risk to expecting moms. On the other hand, pregnancy increases the chance of COVID-19-related severe illness and fatality. On the other hand, pregnant women may be more susceptible to serious, potentially fatal respiratory illnesses. Furthermore, research shows that maternal-fetal transfer occurs via contact with respiratory secretions, excluding transmission in the womb. As a result, the best way to manage breastfeeding is uncertain, and the infant may need to be isolated from the mother for a short time. Finally, because healthcare providers are at a higher risk of infection during birth, further measures must be followed along with a proper management and care plan of both the mother and the health care provider.